| Windlas Biotech Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 543329 |
NSE Symbol : WINDLAS |
P/E(TTM) : 31.01 |
|
ISIN Demat : INE0H5O01029 |
Div & Yield% : - |
EPS(TTM) : 28.50 |
|
Book Value(₹) : 215.47 |
Market Cap(₹Cr) : 1,847.06 |
Face Value(₹) : 5.00 |
| Particulars | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 |
|---|---|---|---|---|---|---|
| Gross Sales | 175.15 | 171.29 | 162.21 | 152.67 | 144.79 | 140.71 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 175.15 | 171.29 | 162.21 | 152.67 | 144.79 | 140.71 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 4.13 | 4.44 | 3.16 | 3.24 | 2.62 | 2.33 |
| Total Income | 179.29 | 175.73 | 165.38 | 155.91 | 147.41 | 143.05 |
| Total Expenditure | 154.27 | 149.35 | 141.88 | 133.99 | 127.64 | 124.27 |
| PBIDT | 25.01 | 26.38 | 23.50 | 21.93 | 19.77 | 18.78 |
| Interest | 0.49 | 0.28 | 0.31 | 0.29 | 0.24 | 0.16 |
| PBDT | 24.52 | 26.10 | 23.20 | 21.64 | 19.53 | 18.61 |
| Depreciation | 6.21 | 3.54 | 3.39 | 3.33 | 3.19 | 3.57 |
| Tax | 4.61 | 4.52 | 4.47 | 4.37 | 3.98 | 4.21 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 0.22 | 1.09 | 0.24 | -0.09 | 0.29 | -0.61 |
| Reported Profit After Tax | 13.48 | 16.95 | 15.10 | 14.03 | 12.07 | 11.45 |
| Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 13.48 | 16.95 | 15.10 | 14.03 | 12.07 | 11.45 |
| EPS (Unit Curr.) | 6.47 | 8.15 | 7.26 | 6.75 | 5.79 | 5.37 |
| EPS (Adj) (Unit Curr.) | 6.47 | 8.15 | 7.26 | 6.75 | 5.79 | 5.37 |
| Calculated EPS (Unit Curr.) | 6.45 | 8.15 | 7.26 | 6.75 | 5.80 | 5.47 |
| Calculated EPS (Adj) (Unit Curr.) | 6.45 | 8.15 | 7.26 | 6.75 | 5.80 | 5.47 |
| Calculated EPS (Ann.) (Unit Curr.) | 25.80 | 32.60 | 29.04 | 26.99 | 23.21 | 21.88 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 25.80 | 32.60 | 29.04 | 26.99 | 23.21 | 21.88 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 10.45 | 10.40 | 10.40 | 10.40 | 10.40 | 10.46 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 14.28 | 15.40 | 14.49 | 14.36 | 13.65 | 13.35 |
| PBDTM(%) | 14.00 | 15.24 | 14.30 | 14.17 | 13.49 | 13.23 |
| PATM(%) | 7.70 | 9.90 | 9.31 | 9.19 | 8.34 | 8.14 |